Year: 2023

SALT LAKE CITY, Nov. 14, 2023 (GLOBE NEWSWIRE) — Security National Financial Corporation (SNFC) (NASDAQ symbol “SNFCA”) announced financial results for the quarter ended September 30, 2023. For the three months ended September 30, 2023, SNFC’s after tax earnings increase nearly 272% from a loss of $2,353,000 in 2022 to a gain of $4,041,000 in 2023. For the nine months ended September 30, 2023, after tax earnings increased 161% to $11,634,000 from $4,450,000 in 2022. Scott M. Quist, President of the Company, said: “I am quite pleased with our Company’s financial performance in the third quarter and year to date. To have triple digit increases over both 2022 third quarter and YTD net income is an excellent performance, especially when considered in light of our tough first quarter. Our Mortgage Segment continues to navigate...

Innofactor Plc Announcement 14.11.2023          Innofactor Plc: Share Repurchase 14.11.2023       In the Helsinki Stock Exchange         Trade date 14.11.2023  Bourse trade Buy  Share IFA1V  Amount 10,000 SharesAverage price/ share 1.0980 EURTotal cost 10,980.00 EUR          Innofactor Plc now holds a total of 471 889 sharesincluding the shares repurchased on 14.11.2023          On behalf of Innofactor Plc         Nordea Bank Oyj         Janne Sarvikivi Sami Huttunen       Additional information:    Sami Ensio, CEO    Innofactor Plc    Tel. +358 50 584 2029    sami.ensio@innofactor.com         www.innofactor.com       AttachmentInnofactor_14.11_trades

PSI and Morbark to feature new 30kw electric powertrain solution during TCI Expo in St. LouisNew PSI Lithium-Ion Power UnitMorbark will feature PSI’s new Lithium-ion power unit during the TCI Expo.Morbark highlighting new PSI electrification optionPSI’s new Lithium-ion power unit will be featured during the TCI Expo in St. Louis.WOOD DALE, Ill., Nov. 14, 2023 (GLOBE NEWSWIRE) — Power Solutions International, Inc. (“PSI” or “the Company”) (OTC Pink: PSIX), a leader in the design, engineering, and manufacture of emission-certified engines and power systems, is proud to announce the latest addition to its range of energy products: the Lithium-ion Power Unit. The 30kw Lithium-ion Power Unit is part of PSI’s New Energy Market Segment offering, designed to capitalize on the electrification efforts of PSI’s...

Press Release Atos collaborates with Microsoft to accelerate business transformation through the application of Microsoft 365 Copilot and Azure OpenAI service Seattle, the United States and Paris, France – November 14, 2023 – Atos today announced the extension of their long-standing partnership with Microsoft to help their clients unlock and scale their Microsoft 365 Copilot and Generative AI deployments. The Atos’ Tech Foundations business line and Microsoft will invest over a 3-year period to build a strategic, comprehensive portfolio to harness the power of data and AI in a secure, efficient and ethical way. The strategic collaboration is structured around three core pillars: solutions, co-creation and competencies. Atos is an early adopter of Microsoft 365 Copilot, providing Microsoft development teams with feedback on its...

CORRECTION: On slide 10 in the attached presentation the numbers in the subtitle has been adjusted from 14,000t to 15,000t  This is done to prevent misunderstanding, the guide is 15,000t the same as is stated in a bulletpoint and was said during the live presentation. Bíldudalur, 9th of November 2023 Icelandic Salmon is the parent company of Arnarlax, and other subsidiaries involved in salmon farming and processing in Iceland. The companies are collectively referred to as “Icelandic Salmon” or the “Group”. Operations In the third quarter 2023, Icelandic salmon resumed harvesting, following a second quarter with limited harvest volume. The group harvested 4,040 tonnes in the quarter, up from 3,804 tonnes in the third quarter 2022. “Our team demonstrated strong adaptability and commitment during a time with changing...

PSI’s gas and electric power units to be on display alongside Morbark equipment at Worlds Largest Tree Care Show WOOD DALE, Ill., Nov. 14, 2023 (GLOBE NEWSWIRE) — Power Solutions International, Inc. (“PSI” or “the Company”) (OTC Pink: PSIX), a leader in the design, engineering and manufacture of emission-certified engines and power systems, announced Morbark, a well-known leader in manufacturing tree care equipment, will feature several of its products during TCI Expo 2023. Morbark will display PSI’s new 30kw lithium-ion power unit as well as two of its chipper models in Booth 1611 during the show, which takes place Nov. 16 through 18 in the America’s Center Convention Complex, 701 Convention Plaza, St. Louis, Mo. The chipper models being featured during the show include models from Morbark’s new BVR brush chipper line, the BVR10,...

Charlotte, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that founder and CEO Jeff Shealy will attend the 14th Annual Craig-Hallum Alpha Select Conference being held at the Sheraton New York Times Square Hotel on November 16, 2023. Investors that would like to schedule a meeting with Akoustis management should contact their Craig-Hallum representative or Akoustis’ investor relations at ir@akoustis.com. Akoustis maintains its momentum with robust demand and an expanding sales pipeline for its XBAW® filter products, in addition to its new XBAW®/SAW resonator and oscillator products, and semiconductor back-end...

Data published in The Journal for ImmunoTherapy of Cancer OCALA, Fla., Nov. 14, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the publication of results from the Phase 1 study at Roswell Park Comprehensive Cancer Center in patients with metastatic triple-negative breast cancer using chemokine modulation therapy, including AIM ImmunoTech Inc.’s drug candidate Ampligen® (also known as rintatolimod), interferon α-2b and celecoxib, followed by pembrolizumab. The data were published in a manuscript titled, “Systemic Infusion of TLR3-Ligand and IFNα in Breast Cancer Patients Reprograms Local Tumor Microenvironment for Selective CTL Influx,” in The Journal for ImmunoTherapy of Cancer. The pilot study evaluated the safety of systemic CKM composed of intravenous rintatolimod (Ampligen;...